PDI, Inc. To Present At The ROTH Capital Partners 26th Annual Growth Stock Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J., March 4, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Jeff Smith, the company's chief financial officer, is scheduled to present at the ROTH Capital Partners 26th Annual Growth Stock Conference at 4:30 pm PT on March 11, 2014 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.

PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise.

The live webcast may be accessed under the "Investor Relations" tab on the company's website at http://www.pdi-inc.com. The webcast will be archived for 30 days.

About PDI, Inc.

PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise. The Company has begun leveraging these substantial capabilities to become a commercialization partner for companies in the molecular diagnostics industry. For more information, please visit the company's website at http://www.pdi-inc.com.

Logo - http://photos.prnewswire.com/prnh/20140114/NY45872LOGO

SOURCE PDI, Inc.



Help employers find you! Check out all the jobs and post your resume.

Back to news